Sarepta Therapeutics plans to raise $375m through the private placement of convertible senior unsecured notes.
Due 15 November 2024, the notes were subscribed to by institutional buyers.
Go deeper with GlobalData
The US-based biopharmaceutical company plans to use the funds to strengthen its balance sheet and for general corporate purposes.
US-based pharmaceutical company Cumberland Pharmaceuticals plans to make a public offering of shares to raise $25m.
The company intends to use the funds towards working capital and general corporate purposes.
CTI BioPharma plans to raise $200m through a public offering of securities issued from time to time.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe securities will include common stock, preferred stock, warrants, rights and units.
The US-based biopharmaceutical company plans to use the funds towards general corporate purposes.
Natco Pharma has announced a public offering of shares to raise Rs15bn ($231.92m).
The Indian pharmaceutical company plans to use the funds to strengthen its domestic formulation business.
